关注
silvana anna maria urru
silvana anna maria urru
APSS Trento
在 apss.tn.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genetic variants regulating immune cell levels in health and disease
V Orrù, M Steri, G Sole, C Sidore, F Virdis, M Dei, S Lai, M Zoledziewska, ...
Cell 155 (1), 242-256, 2013
3962013
Analysis of PIK3CA mutations and activation pathways in triple negative breast cancer
P Cossu-Rocca, S Orrù, MR Muroni, F Sanges, G Sotgiu, S Ena, G Pira, ...
PloS one 10 (11), e0141763, 2015
1132015
Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients
SAM Urru, S Gallus, C Bosetti, T Moi, R Medda, E Sollai, A Murgia, ...
BMC cancer 18, 1-11, 2018
1112018
Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors in a general population
D Piras, M Masala, A Delitala, SAM Urru, N Curreli, L Balaci, LP Ferreli, ...
Nephrology Dialysis Transplantation 35 (4), 640-647, 2020
472020
Role of community pharmacists in the detection of potentially inappropriate benzodiazepines prescriptions for insomnia
SAM Urru, L Pasina, P Minghetti, C Giua
International journal of clinical pharmacy 37, 1004-1008, 2015
372015
Nasopharyngeal swab collection in the suspicion of Covid-19
A Piras, D Rizzo, E Longoni, N Turra, S Urru, PP Saba, L Musumano, ...
American Journal of Otolaryngology 41 (5), 102551, 2020
362020
Prevalence of multiple sclerosis in Sardinia: A systematic cross-sectional multi-source survey
SAM Urru, A Antonelli, GM Sechi, MS Working Group
Multiple Sclerosis Journal 26 (3), 372-380, 2020
362020
Histologic subtyping affecting outcome of triple negative breast cancer: a large Sardinian population-based analysis
F Sanges, M Floris, P Cossu-Rocca, MR Muroni, G Pira, SAM Urru, ...
BMC cancer 20, 1-14, 2020
342020
Acute pancreatitis following brentuximab vedotin therapy for refractory Hodgkin lymphoma: a case report
SAM Urru, E Mariotti, P Carta, S Massidda, M Marcias, R Murru, P Sanna, ...
Drugs in R&D 14, 9-11, 2014
302014
A new fluorogenic peptide determines proteasome activity in single cells
SAM Urru, P Veglianese, A De Luigi, E Fumagalli, E Erba, ...
Journal of medicinal chemistry 53 (20), 7452-7460, 2010
262010
Evidence‐based and unlicensed indications for proton pump inhibitors and patients’ preferences for discontinuation: a pilot study in a sample of Italian community pharmacies
L Pasina, SAM Urru, S Mandelli, C Giua, P Minghetti, SGCP Investigators, ...
Journal of Clinical Pharmacy and Therapeutics 41 (2), 220-223, 2016
232016
Myelodysplastic syndromes and iron chelation therapy
E Angelucci, SAM Urru, F Pilo, A Piperno
Mediterranean Journal of Hematology and Infectious Diseases 9 (1), 2017
222017
Reproducibility of liver iron concentration measured on a biopsy sample: a validation study in vivo
SAM Urru, I Tandurella, M Capasso, E Usala, D Baronciani, C Giardini, ...
American Journal of Hematology 90 (2), 87-90, 2015
162015
Safety of switching between rituximab biosimilars in onco-hematology
SAM Urru, S Spila Alegiani, A Guella, G Traversa, A Campomori
Scientific Reports 11 (1), 5956, 2021
142021
Sex-biased expression of pharmacogenes across human tissues
ML Idda, I Campesi, G Fiorito, A Vecchietti, SAM Urru, MG Solinas, ...
Biomolecules 11 (8), 1206, 2021
122021
Formulation and clinical evaluation of sodium benzoate oral solution for the treatment of urea cycle disorders in pediatric patients
E Maines, SAM Urru, E Burri, G Piccoli, A Pedrolli, A Pasqualini, ...
AAPS PharmSciTech 21, 1-8, 2020
112020
Analysis of current data on the use of topical mTOR inhibitors in the treatment of facial angiofibromas in tuberous sclerosis complex—An update
R Balestri, L Rizzoli, A Pedrolli, SAM Urru, G Rech, I Neri, CR Girardelli, ...
Journal of the European Academy of Dermatology and Venereology 37 (3), 474-487, 2023
102023
Improving clinical paediatric research and learning from COVID-19: Recommendations by the Conect4Children expert advice group
AV Ramanan, N Modi, SN de Wildt
Pediatric Research 91 (5), 1069-1077, 2022
92022
The role of omics approaches to characterize molecular mechanisms of rare ovarian cancers: recent advances and future perspectives
Y Subbannayya, R Di Fiore, SAM Urru, J Calleja-Agius
Biomedicines 9 (10), 1481, 2021
82021
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance
SAM Urru, E Maines, A Campomori, M Soffiati
Human Vaccines & Immunotherapeutics 17 (11), 4112-4114, 2021
72021
系统目前无法执行此操作,请稍后再试。
文章 1–20